Intrexon reported $154.94M in Current Assets for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Current Assets Change
Agenus AGEN:US $ 290.48M 41.49M
Amgen AMGN:US $ 18520M 865M
Anika Therapeutics ANIK:US $ 165.32M 3.21M
Arrowhead Research ARWR:US $ 417.63M 79.35M
AstraZeneca AZN:LN 22.65B 3.6B
Bluebird Bio BLUE:US $ 254.92M 81.6M
Bristol Myers Squibb BMY:US $ 30121M 3141M
Chemocentryx CCXI:US $ 351.63M 82.46M
Gilead Sciences GILD:US $ 12629M 2143M
GlaxoSmithKline GSK:LN 28.99B 10.31B
Heron Therapeutics HRTX:US $ 222.59M 31.83M
Immunogen IMGN:US $ 456.72M 43.28M
Intrexon XON:US $ 154.94M 1.69M
Karyopharm Therapeutics KPTI:US $ 276.53M 927K
Ligand Pharmaceuticals LGND:US $ 276.07M 188.68M
Macrogenics MGNX:US $ 218.2M 61.36M
Mannkind MNKD:US $ 184.26M 35.48M
Merk MRK:US $ 31184M 918M
Novartis NOVN:VX 37.24B 8.48B
Peregrine Pharmaceuticals PPHM:US $ 203.49M 3.43M
Rigel Pharmaceuticals RIGL:US $ 138.94M 15.53M
Sangamo Biosciences SGMO:US $ 340.06M 58.7M
Thermo Fisher Scientific TMO:US $ 18776M 1337M
Veracyte VCYT:US $ 238.48M 4.62M
Xencor XNCR:US $ 505.97M 81.6M
YTE INCY:US $ 3288.09M 169.42M
Ziopharm Oncology ZIOP:US $ 69.77M 9.06M